Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.

Frank W G Leebeek,Flora Peyvandi,Andreas Tiede,Giancarlo Castaman,Miguel Escobar,Michael Wang,Bulent Zülfikar,Sophie Susen,Wolfgang Miesbach,Scarlett Wang,Yi Wang,Jingmei Zhang,Gülden Özen

European journal of haematology（2023）

引用 0|浏览23

暂无评分

摘要

rVWF prophylaxis reduced sABR in type 3 VWD patients previously treated with OD VWF therapy, and maintained a similar level of hemostatic control in those switching from pdVWF prophylaxis to rVWF prophylaxis.

查看译文

关键词

bleeding,prophylaxis,recombinant von Willebrand factor,von Willebrand disease type 3

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要